SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001213900-23-004444 from Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786) (HOTH)

Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786)
Date: Jan. 23, 2023 · CIK: 0001711786 · Accession: 0001213900-23-004444

AI Filing Summary & Sentiment

File numbers found in text: 333-269224

Date
January 23, 2023
Author
Not clearly detected
Form
CORRESP
Company
Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786)

Letter

Hoth Therapeutics, Inc.

1 Rockefeller Plaza, Suite 1039

New York, New York 10020

January 23, 2023

VIA EDGAR

United States Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attention: Arzhang Navai

Re: Hoth Therapeutics, Inc.

Registration Statement on Form S-3

Filed January 13, 2023

File No. 333-269224

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Hoth Therapeutics, Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 5:00 p.m., Eastern Standard Time, on Wednesday, January 25, 2023, or as soon thereafter as possible.

Please notify Nazia Khan of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (202) 747-2651 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.

HOTH THERAPEUTICS, INC.

By: /s/ Robb Knie

Name: Robb Knie

Title: Chief Executive Officer

Show Raw Text
CORRESP
1
filename1.htm

Hoth Therapeutics, Inc.

1 Rockefeller Plaza, Suite 1039

New York, New York 10020

    January 23, 2023

VIA EDGAR

United States Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attention: Arzhang Navai

    Re:
    Hoth Therapeutics, Inc.

    Registration Statement on Form S-3

    Filed January 13, 2023

    File No. 333-269224

Ladies and Gentlemen:

Pursuant to Rule 461
of the General Rules and Regulations under the Securities Act of 1933, as amended, Hoth Therapeutics, Inc. (the “Company”)
respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective
at 5:00 p.m., Eastern Standard Time, on Wednesday, January 25, 2023, or as soon thereafter as possible.

Please notify Nazia Khan of
Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (202) 747-2651 as soon as possible as to the time the Registration
Statement has been declared effective pursuant to this acceleration request.

    HOTH THERAPEUTICS, INC.

    By:
    /s/ Robb Knie

    Name:
     Robb Knie

    Title:
    Chief Executive Officer